Weekly Lonapegsomatropin in Treatment–Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial

CONTEXT: For children with growth hormone deficiency (GHD), treatment burden with daily somatropin injections [human growth hormone (hGH)] is high, which may lead to poor adherence and suboptimal overall treatment outcomes. Lonapegsomatropin (TransCon hGH) is an investigational long-acting, once-wee...

Descripción completa

Detalles Bibliográficos
Autores principales: Thornton, Paul S, Maniatis, Aristides K, Aghajanova, Elena, Chertok, Elena, Vlachopapadopoulou, Elpis, Lin, Zhengning, Song, Wenjie, Christoffersen, Eva Dam, Breinholt, Vibeke Miller, Kovalenko, Tatiana, Giorgadze, Elene, Korpal-Szczyrska, Maria, Hofman, Paul L, Karpf, David B, Shu, Aimee D, Beckert, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530727/
https://www.ncbi.nlm.nih.gov/pubmed/34272849
http://dx.doi.org/10.1210/clinem/dgab529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530727/
https://www.ncbi.nlm.nih.gov/pubmed/34272849
http://dx.doi.org/10.1210/clinem/dgab529

Ejemplares similares